ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v12i1.1255ppharm-477Research ArticleВ ПРАКТИКУ ПЕДИАТРАFor Pediatricians' PracticeЭФФЕКТИВНОСТЬ КОЖНОГО ТЕСТА С АЛЛЕРГЕНОМ ТУБЕРКУЛЕЗНЫМ РЕКОМБИНАНТНЫМ ПРИ ВЫЯВЛЕНИИ ТУБЕРКУЛЕЗА У ДЕТЕЙ И ПОДРОСТКОВ МОСКВЫ В 2013 Г.EFFECTIVENESS OF TUBERCULOUS RECOMBINANT ALLERGEN SKIN TESTS FOR DETECTING TUBERCULOSIS IN CHILDREN AND ADOLESCENTS OF MOSCOW IN 2013СлогоцкаяЛ. В.SlogotskayaL. V.

доктор медицинских наук, заведующая научно-клиническим отделом ГКУЗ «Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы», профессор кафедры фтизиатрии РМАПО

lyu186@yandex.ruСенчихинаО. Ю.SenchikhinaO. Y.НикитинаГ. В.NikitinaG. V.БогородскаяЕ. М.BogorodskayaE. M.Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы, Российская ФедерацияРоссияMoscow Municipal Applied Research Center for Tuberculosis Control of the Department of Health of Moscow, Russian FederationRussian Federation20152108201512199103Copyright © Слогоцкая Л.В., Сенчихина О.Ю., Никитина Г.В., Богородская Е.М., 20152015Слогоцкая Л.В., Сенчихина О.Ю., Никитина Г.В., Богородская Е.М.Slogotskaya L.V., Senchikhina O.Y., Nikitina G.V., Bogorodskaya E.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/477туберкулезкожный тест с аллергеном туберкулезным рекомбинантнымдиагностикатуберкулез у детей и подростковновая кожная пробачувствительностьспецифичностьtuberculosistuberculous recombinant allergen skin testdiagnosistuberculosis in children and adolescentsnew skin testsensitivityspecificityReferencesLein A., von Reyn C., Ravn P. et al. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol. 1999; 6: 606–609.Lein A., von Reyn C., Ravn P. et al. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol. 1999; 6: 606–609.Mahairas G., Sabo P., Hickey M. et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996; 178: 1274–1282.Mahairas G., Sabo P., Hickey M. et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996; 178: 1274–1282.Andersen P., Doherty T., Pai M., Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med. 2007; 13 (5): 175–182.Andersen P., Doherty T., Pai M., Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med. 2007; 13 (5): 175−182.Ewer K., Deeks J., Alvarez L. et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003; 361: 1168–1173.Ewer K., Deeks J., Alvarez L. et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003; 361: 1168–1173.Arend S., Thijsen S., Leyten E. et al. Comparison of two interferongamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007; 175 (6): 618–627.Arend S., Thijsen S., Leyten E. et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med. 2007; 175 (6): 618−627.Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007; 146: 340–354.Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007; 146: 340–354.Mack U., Migliori G., Sester M. et al. LTBI: latent tuberculosis infection or lasting immune responses to Mycobacterium tuberculosis? A TBNET consensus statement. Eur Respir J. 2009; 33: 956–973.Mack U., Migliori G., Sester M. et al. LTBI: latent tuberculosis infection or lasting immune responses to Mycobacterium tuberculosis? A TBNET consensus statement. Eur Respir J. 2009; 33: 956–973.Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008; 149 (3): 177–184.Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008; 149 (3): 177–184.Andersen P., Andersen A., Sorensen A., Nagai S. Recall of longlived immunity to Mycobacterium tuberculosis infection in mice. J Immunol. 1995; 154 (7): 3359–72.Andersen P., Andersen A., Sorensen A., Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol. 1995; 154 (7): 3359−72.Vordermeier H., Chambers M., Cockle P. et al. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun. 2002; 70: 3026–3032.Vordermeier H., Chambers M., Cockle P. et al. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun. 2002; 70: 3026–3032.Dietrich J., Aagaard C., Leah R. et al. Exchanging ESAT6 with ТВ 10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol. 2005; 174: 6332–6339.Dietrich J., Aagaard C., Leah R. et al. Exchanging ESAT6 with ТВ 10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol. 2005; 174: 6332−6339.Bakir M., Millington K., Soysal A. et al. Prognostic value of a T-cell-based, interferon- biomarker in children with tuberculosis contact. Ann Intern Med. 2008; 149: 777–787.Bakir M., Millington K., Soysal A. et al. Prognostic value of a T-cell-based, interferon-γ biomarker in children with tuberculosis contact. Ann Intern Med. 2008; 149: 777–787.Diel R., Loddenkemper R., Meywald-Walter K. et al. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008; 177 (10): 1164–1170.Diel R., Loddenkemper R., Meywald-Walter K. et al. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008; 177 (10): 1164–1170.Doherty T., Demissie A., Olobo J. et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol. 2002; 40 (2): 704–706.Doherty T., Demissie A., Olobo J. et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol. 2002; 40 (2): 704–706.Lienhardt C., Fielding K., Hane A. et al. Evaluation of the Prognostic Value of IFN- Release Assay and Tuberculin Skin Test in Household Contacts of Infectious Tuberculosis Cases in Senegal. PLoS ONE. 2010; 5 (5): e10508. Doi: 10.1371/journal. pone.0010508.Lienhardt C., Fielding K., Hane A. et al. Evaluation of the Prognostic Value of IFN-γ Release Assay and Tuberculin Skin Test in Household Contacts of Infectious Tuberculosis Cases in Senegal. PLoS ONE. 2010; 5 (5): e10508. Doi:10.1371/journal.pone.0010508.Mazurek G., Weis S., Moonan P. et al. Prospective comparison of the tuberculin skin test and two whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis. 2007; 45: 837–845.Mazurek G., Weis S., Moonan P. et al. Prospective comparison of the tuberculin skin test and two whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis. 2007; 45: 837−845.Diel R., Nienhaus A., Schaberg T. Cost-effectiveness of isoniazid chemoprevention in close contacts. Eur Respir J. 2005; 26: 465–473.Diel R., Nienhaus A., Schaberg T. Cost-effectiveness of isoniazid chemoprevention in close contacts. Eur Respir J. 2005; 26: 465–473.Dosanjh D., Hinks T., Innes J. et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med. 2008; 148: 325–336.Dosanjh D., Hinks T., Innes J. et al. Improved diagnostic evaluation of suspected tuber-culosis. Ann Intern Med. 2008; 148: 325–336.Goletti D., Stefania C., Butera O. et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET Study. PLoS ONE. 2008; 3: e3417.Goletti D., Stefania C., Butera O. et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET Study. PLoS ONE. 2008; 3: e3417.Brandli O., Desgrandchamps D., Gabathuler U. et al. Manual of Tuberculosis. Bern, Swiss Lung League. 2007. URL: www.lung.chBrandli O., Desgrandchamps D., Gabathuler U. et al. Manual of Tuberculosis. Bern, Swiss Lung League. 2007. Available at: www.lung.chNational Institute for Health and Clinical Excellence. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. London, National Institute for Health and Clinical Excellence. 2006. URL: www.nice.org.uk.National Institute for Health and Clinical Excellence. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. London, National Institute for Health and Clinical Excellence. 2006. Available at: www.nice.org.uk.The National Collaborating Centre for Chronic Conditions. Tuberculosis. Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control. London, Royal College of Physicians. 2006.The National Collaborating Centre for Chronic Conditions. Tuberculosis. Clinical Diag-nosis and Management of Tuberculosis, and Measures for its Prevention and Control. London, Royal College of Physicians. 2006.Борисов С. Е., Лукина Г. В., Слогоцкая Л. В., Кочетков Я. А., Гунтупова Л. Д., Куликовская Н. В. Скрининг и мониторинг туберкулезной инфекции у ревматологических больных, получающих генно-инженерные биологические препараты. Туберкулез и болезни легких. 2011; 6: 42–50.Borisov S.E., Lukina G.V., Slogotskaya L.V., Kochetkov Ya.A., Guntupova L.D. Kulikovskaya N.V. Screening and monitoring of tuberculosis infection in rheumatic patients receiving genetically engineered biological agents. Tuberkulez i bolezni legkikh = Tuberculosis and Lung Diseases. 2011; 6: 42−50.Mazurek G., Jereb J., Lobue P. et al. Guidelines for using the Quanti FERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005; 54: 49–55.Mazurek G., Jereb J., Lobue P. et al. Guidelines for using the Quanti FERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005; 54: 49–55.Киселев В. И., Барановский П. М., Пупышев С. А. и др. Новый кожный тест для диагностики туберкулеза на основе рекомбинантного белка ESAT-CFP. Молекулярная медицина. 2008; 4: 4–6.Kiselev V.I., Baranovskii P.M., Pupyshev S.A. et al. A new skin test for the diagnosis of tuberculosis based on recombinant protein ESAT-CFP. Molekulyarnaya meditsina = Molecular medicine. 2008; 4: 4–6.Lalvani A., Millington K. A. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis. 2007; 20: 264–271.Lalvani A., Millington K.A. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis. 2007; 20: 264–271.Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest. 2007; 131: 1898–1906.Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest. 2007; 131: 1898–1906.Mori T., Sakatani M., Yamagishi F. et al. Specific detection of tuberculosis infection: an interferon-c-based assay using new antigens. Am J Respir Crit Care Med. 2004; 170: 59–64.Mori T., Sakatani M., Yamagishi F. et al. Specific detection of tuberculosis infection: an interferon-c-based assay using new antigens. Am J Respir Crit Care Med. 2004; 170: 59–64.Pai M., Kalantri S., Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn. 2006; 6: 413–422.Pai M., Kalantri S., Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn. 2006; 6: 413–422.Richeldi L., Ewer K., Losi M. et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann Intern Med. 2004; 140: 709–713.Richeldi L., Ewer K., Losi M. et al. Early diagnosis of subclinical multidrug-resistant tu-berculosis. Ann Intern Med. 2004; 140: 709–713.Слогоцкая Л. В., Сенчихина О. Ю., Богородская Е. М. Чувствительность теста с аллергеном туберкулезным рекомбинантным, содержащим белок ESAT6-CFP10, у впервые выявленных больных туберкулезом детей и подростков в г. Москве. Туберкулез и социально значимые заболевания. 2013; 1: 37–44.Slogotskaya L.V., Senchikhina O.Yu., Bogorodskaya E.M. The sensitivity of the test with the allergen tubercular recombinant protein containing ESAT6-CFP10, in new TB cases of children and adolescents in Moscow. Tuberkulez i sotsial'no znachimye zabolevaniya = Tuberculosis and socially important diseases. 2013; 1: 37−44.

The authors declare that there are no conflicts of interest present.